![Loading Events](https://www.optiknow.ca/wp-content/plugins/the-events-calendar/src/resources/images/tribe-loading.gif)
- This event has passed.
Gene Agnostic Therapies
September 22, 2022 @ 3:00 pm - 4:15 pm
![](https://www.optiknow.ca/wp-content/uploads/2022/08/hey.png)
Over the past few years we have talked a lot about the promise of gene therapy – treatments designed for a specific gene, like Luxturna for RPE56. There is growing interest now in therapies that are not designed for a specific gene – but instead may be able to treat many mutations causing at disease. These potential treatments are called gene agnostic therapies.
In this webinar, join us for a conversation with Dr. Daniel Chung, chief medical officer at SparingVision, which is developing a gene-agnostic therapy to preserve cone vision in people with retinitis pigmentosa, Usher syndrome, and related conditions.